A targeted staff education initiative and a simple visual cue significantly improved clinical awareness of peripheral nerve block complications, specifically fall or injury risks. The study authors...
A targeted staff education initiative and a simple visual cue significantly improved clinical awareness of peripheral nerve block complications, specifically fall or injury risks. The study authors...
A targeted staff education initiative and a simple visual cue significantly improved clinical awareness of peripheral nerve block complications, specifically fall or injury risks. The study authors...
A randomized phase 3 trial evaluated cebranopadol, a dual-NMR agonist, for postoperative pain after abdominoplasty and found reduced pain and opioid use. This study was presented on May 1, 2025, at the ASRA...
A randomized phase 3 trial evaluated cebranopadol, a dual-NMR agonist, for postoperative pain after abdominoplasty and found reduced pain and opioid use. This study was presented on May 1, 2025, at the ASRA...
A randomized phase 3 trial evaluated cebranopadol, a dual-NMR agonist, for postoperative pain after abdominoplasty and found reduced pain and opioid use. This study was presented on May 1, 2025, at the ASRA...
A randomized phase 3 trial evaluated cebranopadol, a dual-NMR agonist, for postoperative pain after abdominoplasty and found reduced pain and opioid use. This study was presented on May 1, 2025, at the ASRA...
A randomized phase 3 trial evaluated cebranopadol, a dual-NMR agonist, for postoperative pain after abdominoplasty and found reduced pain and opioid use. This study was presented on May 1, 2025, at the ASRA...
A randomized phase 3 trial evaluated cebranopadol, a dual-NMR agonist, for postoperative pain after abdominoplasty and found reduced pain and opioid use. This study was presented on May 1, 2025, at the ASRA...
Anticoagulation after trauma reduces the risk of stroke and transient ischemic attacks without significantly increasing bleeding or readmissions, according to the results of a study presented at the Society...
